Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection

Cytokine-induced killer (CIK) cell therapy has recently been used as an adjuvant setting following resection of hepatocellular carcinoma (HCC), while its benefit remains unclear. This study aimed to evaluate the efficacy of adjuvant CIK application in solitary HCC patients undergoing curative resect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Chen, Jian-Lin, Lao, Xiang-Ming, Lin, Xiao-Jun, Xu, Li, Cui, Bo-Kang, Wang, Jun, Lin, Guo-He, Shuang, Ze-Yu, Mao, Yi-Ze, Huang, Xin, Yun, Jing-Ping, Jin, Jie-Tian, Li, Sheng-Ping
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2016
Assuntos:
7300
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748913/
https://ncbi.nlm.nih.gov/pubmed/26844496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002665
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados